- Home
- KALU vs OPK Comparison
KALU vs OPK Comparison
Compare KALU & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALU
- OPK
- Stock Information
- Founded
- KALU 1946
- OPK 2007
- Country
- KALU United States
- OPK United States
- Employees
- KALU N/A
- OPK N/A
- Industry
- KALU Metal Fabrications
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- KALU Industrials
- OPK Health Care
- Exchange
- KALU Nasdaq
- OPK Nasdaq
- Market Cap
- KALU 1.1B
- OPK 1.0B
- IPO Year
- KALU 1991
- OPK 1995
- Fundamental
- Price
- KALU $70.20
- OPK $1.59
- Analyst Decision
- KALU Buy
- OPK Strong Buy
- Analyst Count
- KALU 2
- OPK 3
- Target Price
- KALU $90.00
- OPK $2.75
- AVG Volume (30 Days)
- KALU 84.8K
- OPK 2.9M
- Earning Date
- KALU 02-19-2025
- OPK 02-25-2025
- Dividend Yield
- KALU 4.40%
- OPK N/A
- EPS Growth
- KALU 252.66
- OPK N/A
- EPS
- KALU 2.90
- OPK N/A
- Revenue
- KALU $2,980,300,000.00
- OPK $711,408,000.00
- Revenue This Year
- KALU N/A
- OPK N/A
- Revenue Next Year
- KALU $6.84
- OPK $0.00
- P/E Ratio
- KALU $24.16
- OPK N/A
- Revenue Growth
- KALU N/A
- OPK N/A
- 52 Week Low
- KALU $60.71
- OPK $0.86
- 52 Week High
- KALU $102.42
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- KALU 42.74
- OPK 60.76
- Support Level
- KALU $68.27
- OPK $1.47
- Resistance Level
- KALU $70.58
- OPK $1.51
- Average True Range (ATR)
- KALU 2.03
- OPK 0.04
- MACD
- KALU -0.04
- OPK 0.01
- Stochastic Oscillator
- KALU 24.97
- OPK 80.00
About KALU Kaiser Aluminum Corporation
Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.